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Abstract 
BACKGROUND: Irbesartan and hydrochlorothiazide are a group of anti-hypertensive drugs that are very effective 
and safe to use to reduce blood pressure and oedema. The combination has a small active ingredient content so 
that if the treatment didn't meet the requirements for therapeutic doses, it not achieved to the maximum therapy. 
AIM: The research aims to the simultaneous determination of irbesartan and hydrochlorothiazide in tablets by 
Ratio subtraction spectrophotometry method. 
METHODS: The absorption spectra and sample measurement in the Ratio subtraction method performed on 
Irbesartan at a wavelength of 247.6 nm and 273.6 nm for the Hydrochlorothiazide (HCT) using 0.1 N NaOH as a 
solution. This method is validated with linearity, accuracy, and precision in intraday and interday, LOD and LOQ 
and applied in the determination of a mixture of irbesartan and hydrochlorothiazide in the dosage tablet. 
RESULTS: The validation test for IRB is 101.03 for accuracy, with a precision of 0.57; with precision testing at 
intraday 0.34 and interday 1.34, and LOD is 0.70 and LOQ is 2.12. Meanwhile, validation for HCT that the 
accuracy 100.34%; precision 0.89 and precision on intraday 1.20 and interday 1.18, and LOD 0.78 and LOQ 2.37 
with IRB levels are 101.03 ± 0.63% and HCT is 100.59 ± 0.91%. 
CONCLUSION: The ultraviolet spectrophotometric method in subtraction ratio method was validated a method of 
linearity, accuracy, precision in intraday and interday, LOD, and LOQ and according to ICH guidelines and 
successfully applied for the determination simultaneous of irbesartan and hydrochlorothiazide in the tablet's 
dosage form. 
 
 
 
 
Introduction 
 
Clinically the problem-related side effects may 
be solved by introducing low-dose combination drugs 
for first-line antihypertensive therapy. The combination 
of Irbesartan and Hydrochlorothiazide is one of the 
right combinations for antihypertensive and effective 
to reduce blood pressure and oedema in hypertensive 
patients who are usually accompanied by 
complications and minimal side effects, namely 
hyperkalemia [1]. The combined use of angiotensin 
receptor (AR) blockers and diuretics is better 
tolerated, but more costly, than generic ACE inhibitors 
and diuretics, mostly because of the absence of 
cough and much lower incidence of angioedema [2]. 
Irbesartan (IRB), with chemically names 2-
Butyl-3 - [[20- (1H-tetrazole-5-yr) [1, 10-biphenyl] -4-yl] 
methyl] 1, 3-diazaspiro [4.4] non-1 -en-4-one is 
angiotensin II receptor (ARB) inhibitors are used to 
treat hypertension and diabetic nephropathy. Because 
blood vessels can narrow due to the influence of 
angiotensin II and serves to inhibit these effects, thus 
dilating blood vessels and reducing pressure on blood 
vessels [3]. Irbesartan is an angiotensin II antagonist 
(AT1 receptor subtype) which is the primary 
vasoactive hormone involved in RAAS and a strong 
vasoconstrictor, and is formed from angiotensin I 
through a reaction catalysed by angiotensin-
converting enzyme (ACE, kininase II). Irbesartan 
works against angiotensin II by blocking the effects of 
vasoconstrictor and aldosterone secretion from 
angiotensin II by binding selectively to the angiotensin 
II AT1 receptor [4]. 
Hydrochlorothiazide (HCT), with chemical 
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names 6-Chloro-3, 4-dihydro-2H-1, 2, 4-
benzothiadiazine-7-sulfonamide 1, 1 dioxide is a 
group of diuretics and first-line drug therapy for the 
treatment of hypertension. Thiazide diuretics class of 
highly effective in preventing stroke and heart failure 
in patients with hypertension [3]. Hydrochlorothiazide 
is a treatment for mild to moderate hypertension. 
Often in more severe cases combined with other 
drugs to strengthen the effect, especially beta-
blockers. Combination of ACE inhibitors, reducing 
resistance to activated renin-angiotensin-aldosterone 
system (RAAS) [2].  
The combination of IRB with HCT significantly 
reduces BP in patients not controlled by IRB or HCT 
alone. The addition of IRB had positive effects on 
HCT induced biochemical abnormalities. In matrix 
studies, IRB appeared to blunt hypokalemia 
associated with HCT, and uric acid and total 
cholesterol levels were lower with the combination 
than with HCT monotherapy. IRB did not increase the 
HCT associated increases in serum triglycerides. 
Finally, IRB-HCT combination brings positive effects 
of IRB on undesired effects of diuretic, provides 
advantages of AR blockade, decreases resistance 
because of activated RAAS, simplifies treatment 
regimen, besides providing better BP control. 
Moreover, HCT may increase protective organ 
benefits of the AR antagonist by providing better BP 
control in this combination [1], [2], [4], [5], [6], [7]. 
The Irbesartan level was determined by 
ultraviolet spectrophotometry with acid solvents at 
wavelengths 224 and 246 nm, and 
hydrochlorothiazide assayed by ultraviolet 
spectrophotometry in an alkaline solvent at a 
wavelength of 274 nm and high-performance liquid 
chromatography method with buffer-acetonitrile 
mobile phase P (6: 4) and a mixture of monobasic 
sodium phosphate P 0.1 P M-acetonitrile (9: 1)) [3], 
[8]. Several articles have been published regarding 
the determination of the mixture of irbesartan and 
hydrochlorothiazide levels, among others, by using 
high-performance liquid chromatography, by capillary 
electrophoresis [8], [9], the zero-crossing method with 
spectrophotometry [10].  
Spectrophotometry is a simple, fast and 
relatively easier method compared to other methods 
but the main problem with a mixture of binary or 
ternary spectrophotometry analysis is the 
determination of compounds simultaneously in the 
same mixture of drugs without prior separation [3.7]. 
Several studies of simultaneous spectrophotometric 
determination of the combinations of IRBs and HCTs 
have been published, among others, methods the 
zero-crossing method with spectrophotometry, 
Simultaneous equation and absorbance ratio, ratio 
subtraction coupled with constant multiplication, ratio 
difference and constant centre [9], [10], [11]. 
Ratio subtraction method (RSM) is one of the 
spectrophotometric methods that can be used to 
analyse two or more mixtures of drugs simultaneously 
without having to do a separation, easily applied to the 
routine analysis and without the need for 
derivatisation first. Several articles on the 
establishment of a mixture by using RSM has 
published, among others, the determination of 
omeprazole, tinidazole, and clarithromycin with 
ethanol, Benazepril and amlodipine with methanol and 
Timolol and dorzolamide [12], [13], [14], [15]. The ratio 
subtraction method shows that this method is very 
simple, accurate, and does not require complicated 
mathematical calculations using only constants in the 
spectrum of ratios that can be applied to the IRB and 
HCT levels. [16], [17], [18]. 
 The purpose of this study is to prove the 
subtraction ratio method can be used to determine 
IRB and HCT levels in tablet dosage forms. 
 
 
Material and Methods 
 
Material 
Pharmaceutical grades of IRB were from the 
National Agency of Drug and Food Control of the 
Republic of Indonesia, HCT was from PT Kimia 
Farma. Tablet C (PT. Sanofi) contained 300 mg IRB 
and 12.5 mg HCT, NaOH, Methanol. 
 
Apparatus and conditions 
UV-Visible Spectrophotometer (Shimadzu 
1800) with a computer equipped with UV probe 2.43 
software (UV-1800 Shimadzu), the absorption was 
recorded at a wavelength of 200-400 nm using UV-
probe software, Analytical balance (Sartorius), 
sonicator (Branson 1510). 
 
Preparation of standard stock solution 
Carefully weighed of 50 mg IRB and HCT, 
then transferred to a 50 mL volumetric flask dissolved 
it in 0.1 N NaOH by adding it to the line. Stock solution 
concentration was 1000 µg/ml. Pipetted 5 mL of stock 
solution transferred to a 50 mL volumetric flask diluted 
it using 0,1 N NaOH by adding it to the line, and the 
concentration would be 100 µg/mL that is working 
solution. 
 
Validation test 
The solution standard for IRB and HCT for 
absorption spectrum was made by the selected 
wavelength points 247.6 nm for IRB, while the HCT 
used wavelengths of 273.4 nm. Determined zero 
orders from series C are used after manipulate to get 
a regression equation for each component [19], [20]. 
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Precision  
Reparability of the methods was studied by 
repeating the methods six times. To study intra-day 
precision, a method was repeated three times in a 
day. Similarly, the method was repeated on three 
different days to determine inter-day precision. 
The determination of precision is based on 
the relative standard deviation (RSD) value 2% [19], 
[20]. 
 
Intraday and interday precision 
Intraday and interday are precision 
measurements with simultaneous samples. Intraday is 
a repetition that is done every day in one day, during 
every day at certain hours in a few days. Intraday and 
repetition at each concentration. Intraday is three 
repetitions on the same day (morning, afternoon, 
evening) and three repetitions with 3 different days 
(days 1, 2, 3). Determination of interday and intraday 
precision was seen from its relative standard deviation 
< 2.5% [19]. 
 
Accuracy 
Accuracy test was calculated by measured 
recovery percentage in three specific points which 
were: 80%, 100%, and 120%. In each of the specific 
points, the test used 70% from the sample and 30% 
from the pure active substances (standard addition 
method) [19], [20]. 
 
Construction of Absorption Maximum 
 Spectrum and Ratio Absorption Spectrum 
The working solution was pipetted each 
containing 10 μg/mL IRB and 8 μg/mL HCT and a 
mixed solution of 10 μg/mL IRB and 8 μg/mL HCT 
then each transferred in a 25 mL volumetric flask 
Diluted using 0.1 N NaOH, and measured the 
absorption spectrum. Furthermore, are used 5-15 
μg/mL IRB solution and 4-12 μg/mL for HCT and a 
mixture of the two drugs in the same range and 
prepared for made an absorption spectrum of RSM 
then scanned in the range of 200-400 nm and 
overlapped the third spectrum. Useful for the ratio 
subtraction method (RSM) extended ratio subtraction 
method (EXRSM) method, where the mixture of IRB 
and HCT shows overlapped spectra, IRB represents 
unextended spectrum and HCT representing an 
extended-spectrum [3], [9], [10]. 
 
Determination IRB and HCT mixture by 
 RSM 
The IRB and HCT can determined by using 
the ratio subtraction method by a standard spectrum 
of 8 µg/mL HCT´ as a divisor producing a new curve 
that represents IRB/HCT´ + HCT/HCT´ (constant ) and 
10 µg/mL IRB as a divisor producing a new curve that 
represents HCT/IRB´ + IRB /IRB´ (constant ). Then 
the curve is subtracted with constant values 
(HCT/HCT´) and (IRB /IRB´), then multiplication curve 
by the standard spectrum of 8 µg/mL HCT´ for IRB 
and 10 µg/mL IRB´ for HCT which is the same divisor 
used, therefore the obtained spectrum is zero-order 
absorption spectrum of IRB and HC. Then can be 
summarised as the following [8], [9]: 
 
 
 
 
Determination of the constants directly 
derived from the curve with a straight line parallel to 
the X-axis is the wavelength in the region where y 
expanded 
Note: X = IRB; Y = HCT; Y° = HCT is Divisor; 
and X° = IRB as Divisor. 
The concentrations of IRB and HCT are 
calculated using the linear relationship between the 
absorbance at its λ max versus the corresponding 
concentration [8], [9]. 
 
Preparation of sample solution 
Twenty tablets are weighed and crushed 
homogeneous. Furthermore, weighed the amount of 
powder equivalent to 300 mg of IRB and 12.5 mg of 
HCT and the equality of TRI contained in there is 
calculated. It should be weighed up to six repetitions. 
Subsequently incorporated into the flask 50 mL and 
diluted with 0.1N NaOH (with sonicator for 15 
minutes), and then paid back with 0.1 N NaOH until 
the line mark, shaken until homogeneous. The 
solution is then filtered, approximately 10 mL of the 
first filtrate discarded. Taken 0.5 mL, put in a 25 mL 
flask and paid back with diluted with 0.1 N NaOH until 
the line marks to obtained solution in which there are 
IRB and HCT concentration of 10 μg/mL and 8 μg/mL, 
respectively. Measured absorption was at a 
wavelength of 200-400 nm. 
 
 
Results 
 
Spectrum overlapping studies were obtained 
from the maximal absorption spectrum of IRB and 
HCT as well as a mixture of IRB and HCT. In the 
maximal absorption spectrum of IRB the concentration 
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of 10 µg/ml was used and for HCT concentrations of 8 
µg/ml, a ratio of 5: 4 was obtained for the IRB and 
HCT respectively and can be seen at Figure 1. 
 
Figure 1: Overlain spectrum of IRB (10 µg/mL), HCT (8 µg/mL) and 
mixture (IRB 10 and HCT 8 µg/mL) 
 
Based on Figure 1, the overlapping spectrum 
of IRB and HCT shows that HCT is more extended 
than IRB so that HCT is used as the initial divisor for 
the subtraction method ratio. According to Kamal et al. 
(2016), the determination of overlapping spectrum 
studies is the starting point for determining the levels 
using the ratio subtraction method. This analysis of 
the use of length used for analysis, which shows that 
the initial divisor is used for the ratio subtraction 
method, where the initial divisor is used the next step 
[8]. 
 
Method validation 
The developed method is validated for 
linearity, precision, and accuracy. The validation 
results are shown in Table 1. 
Table 1: Validation Methods of IRB and HCT in Ratio 
subtraction method 
No. Parameter IRB HCT 
1 Analytical wavelengths 247.6 nm 273.6 nm 
2 Concentration (µ/ml 5-15 4-12 
3 Regression equation Yirb = 0.0482X - 0.0083 Yhct= 0.0585X – 0.0068 
4 Correlation coefficient 0.9994 0.9988 
5 Accuracy (%) 101.03 100.59 
6 Precision (RSD) (%) 0.57 0.89 
7 Interday (% RSD) 1.34 1.18 
8 Intraday (% RSD) 0.34 1.20 
9 LOD (µg/mL) 0.70 0.78 
10 LOQ (µg/mL) 2.12 2.37 
 
Based on Table 1, It can be seen that the 
calibration curves of IRB and HCT were linear in the 
range of 5-15 µg/mL and 4-12 µg/mL, 
respectively.The regression equations of calibration 
curves were Yirb = 0.0482X - 0.0083, r = 0.9994 for 
IRB and Yhct= 0.0585X – 0.0068, r = 0.9988 for HCT. 
Relative standard deviations (% R.S.D.) for interday 
were found to be 1.34 and 1.18 for IRB and HCT, 
respectively. The intraday precision showed % R.S.D 
0.34 and 1.20 for IRB and HCT, respectively. The 
LOD for IRB and HCT was found to be 0.7005 µg/mL 
and 0.7834 µg/mL respectively. The LOQ for IRB and 
HCT was found to be 2.1227 µg/mL and 2.3741 
µg/mL respectively. Based on the table above shows 
all the interday and intraday results meet the 
requirements < 2% RSD, this means that the RSM 
method can be stated to have good precision because 
after testing on intra-day and intra-day it gives 
insignificant results in statistical calculations and 
meets ICH requirements 2015 [19]. 
 
Accuracy 
The percentage recoveries of a drug from 
marketed formulation were determined by standard 
addition of pure drugs at three (80%, 100%, and 
120%) known concentrations and excellent recoveries 
were obtained at each level. The accuracy studies are 
shown in Table 2 
Table 2: Accuracy study  
No. Drug Concentration (%) Mean % recovery 
1 IRB 80 % 100.97 
2 IRB 100% 101.08 
3 IRB 120% 101.03 
4 HCT 80 % 99.80 
5 HCT 100% 100.37 
6 HCT 120% 100.37 
 
The percentage of recovery for IRBs is three 
levels, 80%, 100%, and 120% respectively 100.97, 
101.08 and 101.03, while for HCT is 99.80, 100.37 
and 100.37, that is mean the validation of RSM is a 
requirement with ICH 2015 [19]. 
 
Ratio Subtraction Method 
This method is operated using the UV probe 
2.43 application by doing a manipulate from the data 
set spectrum, when the mixtures of IRB and HCT, 
where the spectrum of HCT is more extended, the 
determination of IRB in the mixture can be done by 
scanning the zero-order spectra of IRB and HCT, 
dividing them by a carefully chosen concentration of 
HCT´ standard (8 µg/mL) as a divisor. The choice of 
this divisor is very crucial because it can affect the 
results of the spectrum obtained. After dividing the 
new ratio, the spectrum is generated which represents 
IRB/HCT´ + constant as in Figure 2 (step 1).  
 
Figure 2: Spectra of mixtures IRB and HCT using 8 µg/mL of HCT´ 
as a divisor 
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The results of the spectrum are subtracted 
constant, namely HCT/HCT´ to produce the spectrum 
shown in Figure 3 (step 2). 
 
Figure 3: Spectra of mixtures IRB and HCT using 8 µg/mL of HCT´ 
as a divisor and after subtraction with constants (HCT/HCT´) 
 
 Then proceed with the multiplication of the 
obtained spectra by the divisor HCT´ (8 µg/mL) as 
shown in Figure 4.  
 
Figure 4: The zero-order absorption spectra of IRB by the proposed 
RSM after multiplication by the divisor 
 
Finally, the original spectra of IRB can be 
obtained, Figure 4, which was used for direct 
estimation of IRB at 247.6 and calculation. The 
concentration of zero-order curves of IRB at 247.6 
against the corresponding concentrations. 
The determination of HCT can be obtained by 
the spectra of IRB by a carefully chosen concentration 
of the standard IRB´ (10 µg/mL) producing ratio 
spectra representing the constants IRB/IRB´. The 
scanned zero-order IRB and HCT were divided by the 
IRB´ (10 µg/mL) standard as a product of the new 
ratio spectra which represent HCT/IRB´ + constant as 
shown in Figure 5. 
 
Figure 5: Spectra of Mixtures IRB and HCT using 10 µg/mL of IRB´ 
as a divisor 
 
 The spectra are subtracted by the constant 
so that the new ratio spectra, which represent 
HCT/IRB´ are shown in Figure 6.  
 
Figure 6: Spectra of Mixtures IRB and HCT using 10 µg/Ml Of IRB´ 
as a divisor after Subtraction with Constants (IRB/IRB´) 
 
Then the spectra are multiplication by the 
IRB´ divisor (10 µg/mL) which is the same as before. 
Finally, the original spectra of HCT, Figure 7, which 
can be used for determination of HCT at 273.4 nm in 
the form of corresponding regression equation curves 
of HCT at 273.4 nm against the corresponding).  
 
Figure 7: The Zero Order Absorption Spectra of HCT By The 
Proposed RSM 
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The methods are considered to be 
complementary to each other as the two components 
of interest in the mixture can be determined. The 
results obtained upon using the suggested methods 
for the analysis of IRB and HCT in marked tablets.  
Table 3: Results of simultaneous estimation of IRB and HCT by 
RSM 
Component Claim on the label (mg) The content (mg) 
IRB 300 313.60 ± 1.88 
HCT 12.5 12.66 ± 0.20 
 
Based on Table 3 can be seen that the 
proposed ratio subtraction method gives accurate and 
precise have been developed and validated for 
irbesartan and hydrochlorothiazide in the marketed 
formulation (tablets) without prior separation and is 
easily applied for routine analysis. The most 
interesting feature of the ratio subtraction method is its 
simplicity and rapidity. The validation method has 
been demonstrated by a variety of tests for linearity, 
accuracy, and precision. The proposed methods were 
successfully applied to the determination of these 
drugs in commercial tablets. 
 
 
Discussion 
 
Based on the result above, it can be seen that 
there are irbesartan and hydrochlorothiazide mixture 
in the tablet dosage form is a requirement for 
Indonesian pharmacopoeia. This method means that 
pharmaceutical preparations containing the 
composition of the two substances can be used as a 
mixture of anti-hypertensive drugs. Its combination is 
primarily indicated for moderate-to-severe 
hypertension, but it could be useful for other 
irbesartan indications, as well. The combination 
significantly reduces BP in patients not controlled by 
IRB or HCT alone. Therefore, it is possible to evaluate 
the clinical efficacy under 2 main titles: BP-lowering 
efficacy, and the end-organ protection. The 
combination are fixed-dose combinations achieved BP 
targets in 77% of patients with systolic, 83% for 
diastolic and 69% for both BP levels [1], [2], [4], [5], 
[6], [7] 
 
 
Acknowledgement 
 
The authors wish to thank for Minister of 
Research, Technology and Higher Education of 
Republic Indonesia, Prof. Runtung., Rector of 
Universitas Sumatera Utara and Prof Erman Munir., 
Chairman of the USU Research Institutes in 
conducting appointment of research implementation of 
DRPM KEMENRISTEKDIKTI for Thesis Research 
Scheme no 202/UN5.2.3.1 /PPM/KP. DRPM/2019 
 
 
References 
 
1. Derosa G, Ferrari I, Cicero AF. Irbesartan and 
hydrochlorothiazide association in the treatment of hypertension. 
Curr Vasc Pharmacol. 2009; 7(2):120-36. 
https://doi.org/10.2174/157016109787455644 PMid:19355995 
2. ESH/ESC Hypertension Practice Guidelines Committee, 
2007Guidelines for the Management of Arterial Hypertension. J 
Hypertens. 2007; 25:1105-87. 
https://doi.org/10.1097/HJH.0b013e3281fc975a PMid:17563527 
 
3. Moffat AC, Osselton MD, Widdop B. Clarke's Analysis of Drugs 
and Poisons, 4th ed., no. 1. London: Pharmaceutical Press, 2011.  
4. Zanchetti A, Parati G, Malacco E. Zofenopril plus HCTZ: 
combination therapy for the treatment of mild to moderate 
hypertension.Drugs 2006; 66:1107-15. 
https://doi.org/10.2165/00003495-200666080-00006 
PMid:16789795 
 
5. Waeber W. Combination therapy with ACE inhibitors/angiotensin 
I receptor antagonists and diuretics in hypertension. Expert Rev 
Cardiovasc Ther. 2003; 1:43-50. 
https://doi.org/10.1586/14779072.1.1.43 PMid:15030296 
 
6. Raskin P, Guthrie R, Flack JM, Reeves RA, Saini R. The long-
term antihypertensive activity and tolerability of irbesartan with 
hydrochlorothiazide. J Hum Hypertension. 1999; 13:683-87. 
https://doi.org/10.1038/sj.jhh.1000888 PMid:10516738 
 
7. Government of Indonesia. Indonesian pharmacopeia. 5thed. 
Jakarta: Indonesian Health Ministry, 2014.  
8. Kamal AH, El-malla SF, Hammad SF. A Review on Uv 
Spectrophotometric Methods for Simultaneous Multicomponent 
Analysis. European Journal of Pharmaceutical and Medical 
Research. 2016; 3(2):348-360. 
 
9. Raja B, Himasri P, Ramadevi B. RP-HPLC method for the 
simultaneous estimation of irbesartan and hydrochlorothiazide in a 
pharmaceutical dosage form. International Research Journal of 
Pharmaceutical and Applied Sciences. 2012; 2(3):29-38. 
 
10. Dal AG, Koyutürk S. Simultaneous Determination of Irbesartan 
and Hydrochlorothiazide in Tablets by CE-DAD. J Biol & Chem. 
2015; 43(3):145-14. 
 
11. Albero I, Ródenas V, Garc  a S, Sánchez-Pedreño C. 
Determination of irbesartan in the presence of hydrochlorothiazide 
by derivative spectrophotometry. Journal of Pharmaceutical and 
Biomedical Analysis. 2002; 29(1-2):299-305. 
https://doi.org/10.1016/S0731-7085(02)00073-0 
 
12. Fayez YM. Simultaneous determination of some anti-
hypertensive drugs in their binary mixture by novel 
spectrophotometric methods. Spectrochimica Acta-Part A: 
Molecular and Biomolecular Spectroscopy. 2014; 132:446-451. 
https://doi.org/10.1016/j.saa.2014.04.102 PMid:24887506 
 
14. Lotfy HM, Abdel-Monem HM. Comparative study of novel 
spectrophotometric methods manipulating ratio spectra: An 
application on a pharmaceutical ternary mixture of omeprazole, 
tinidazole, and clarithromycin. Spectrochimica Acta-Part A: 
Molecular and Biomolecular Spectroscopy. 2012; 96:259-270. 
https://doi.org/10.1016/j.saa.2012.04.095 PMid:22683662 
 
15. El-Ghobashy MR. Abo-Talib NF. Spectrophotometric methods 
for the simultaneous determination of a binary mixture of 
metronidazole and diloxanide furoate without prior separation J 
Adv Res. 2010; (1)4:323-29. 
https://doi.org/10.1016/j.jare.2010.06.001 
 
16. Marwada KR, Patel JB, Patel NS, Patel BD, Borkhatariya DV, 
Patel AJ. Ultraviolet spectrophotometry (dual wavelength and  
Public Health 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
2946                                                                                                                                                                                              https://www.id-press.eu/mjms/index 
 
chemometric) and high-performance liquid chromatography for 
simultaneous estimation of meropenem and sulbactam sodium in a 
pharmaceutical dosage form. Spectrochimica Acta-Part A: 
Molecular and Biomolecular Spectroscopy. 2014; 124:292-99. 
https://doi.org/10.1016/j.saa.2014.01.008 PMid:24495837 
17. Ali NW, Abdelwahab NS. Spectrophotometric Methods for 
Simultaneous Determination of Two Hypouricemic Drugs in their 
Combined Dosage Form. Pharm Anal Acta. 2013; (04)06:4-11. 
https://doi.org/10.4172/2153-2435.1000255 
 
18. Farouk M, Elaziz OA, Tawakkol SM, Hemdan A, Shehata MA, 
Comparative study between univariate spectrophotometry and 
multivariate calibration as analytical tools for quantitation of 
Benazepril alone and in combination with Amlodipine, Spectrochim. 
 
Acta - Part A Mol Biomol Spectrosc. 2014; 123:473-81. 
https://doi.org/10.1016/j.saa.2013.12.094 PMid:24424258 
19. U.S. Food and Drug Administration, Analytical Procedures and 
Methods Validation for Drugs and Biologics, 2015. 
http://www.fda.gov/ BiologicsBloodVaccines/GuidanceCompliance 
Regulatory Information /Guidances/default.htm 
 
20. Ermer J, John JH. Method Validation in Pharmaceutical 
Analysis: A Guide to Best Practice. Weinheim, FRG: Wiley-VCH 
Verlag GmbH & Co. KGaA, 2005. 
https://doi.org/10.1002/3527604685 
 
 
